A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study (vol 27, pg 318, 2010)

被引：3
|
作者：
Filozof, C.
Gautier, J-F
机构：
来源：
DIABETIC MEDICINE | 2013年 / 30卷 / 05期
关键词：
D O I：
10.1111/dme.12167
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：632 / 632
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Gemigliptin Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
    Rhee, Eun Jung
    Min, Kyung Wan
    Jang, Hak Chul
    Nam-Goong, Il Seong
    Chung, Choon Hee
    Park, Joong Yeol
    Bae, Hak Yeon
    Kim, Doo-Man
    Baik, Sei Hyun
    Lee, Moon-Kyu
    Kim, Byung-Joon
    Chang, Sang Ah
    Ahn, Chul Woo
    Kim, Yong Seong
    Yoon, Kun Ho
    Park, Kyong Soo
    Kim, Hae Jin
    Shivane, Vyankatesh K.
    Sosale, Aravind R.
    Dharmalingam, Mala
    Gandhi, Pramod
    Gupta, Sandeep Kumar
    Pitale, Shailesh
    Agarwal, Pankaj Kumar
    Rais, Nadeem
    Mohan, V.
    Mahesh, Uma
    Kim, Jeong Ae
    Kim, Pan Kyung
    Kim, Sun Woo
    DIABETES, 2012, 61 : A291 - A291
  • [22] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    DIABETOLOGIA, 2012, 55 : S352 - S352
  • [23] Efficacy and safety of sitagliptin added to ongoing metformin therapy in type 2 diabetes patients who were inadequately controlled on metformin alone
    Meininger, G.
    Charbonnel, B.
    Karasik, A.
    Liu, J.
    Wu, M.
    Meehan, A.
    DIABETOLOGIA, 2006, 49 : 5 - 6
  • [24] Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
    Ferrannini, E.
    Fonseca, V.
    Zinman, B.
    Matthews, D.
    Ahren, B.
    Byiers, S.
    Shao, Q.
    Dejager, S.
    DIABETES OBESITY & METABOLISM, 2009, 11 (02): : 157 - 166
  • [25] Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Gao, Yan
    Yoon, Kun Ho
    Chuang, Lee-Ming
    Mohan, Viswanathan
    Ning, Guang
    Shah, Sanjiv
    Jang, Hak Chul
    Wu, Ta-Jen
    Johns, Don
    Northrup, Justin
    Brodows, Robert
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 69 - 76
  • [26] Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
    Rombopoulos, Grigorios
    Hatzikou, Magdalini
    Athanasiadis, Athanasios
    Elisaf, Moyses
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [27] Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial
    Goeke, Burkhard
    Gallwitz, Baptist
    Eriksson, Johan G.
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (04) : 307 - 316
  • [28] Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results
    Ristic, S.
    Collober-Maugeais, C.
    Cressier, F.
    Tang, P.
    Pecher, E.
    DIABETES OBESITY & METABOLISM, 2007, 9 (04): : 506 - 511
  • [29] Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
    Dandona, Paresh
    Mathieu, Chantal
    Phillip, Moshe
    Hansen, Lars
    Tschoepe, Diethelm
    Thoren, Fredrik
    Xu, John
    Langkilde, Anna Maria
    DIABETES CARE, 2018, 41 (12) : 2552 - 2559
  • [30] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
12345